5 Best Biotech Stocks Under $6 in 2021

2. MediWound Ltd. (NASDAQ: MDWD)

Number of Hedge Fund Holders: 2
Price as of April 19, 2021: $4.91 per share

MediWound Ltd. (NASDAQ: MDWD) is an Israel-based company that concentrates on the development and manufacture of therapeutics based on a patented proteolytic enzyme technology. These therapeutics are used to treat severe burns, chronic and other wounds. One of the drugs made by the firm, called NexoBrid, is used for the removal of eschar, a dead or damaged tissue in adults. MediWound also makes EscharEx, a drug that treats chronic and other wounds and is currently in advanced clinical trials. 

MediWound Ltd. was founded in 2000 and is placed second on our list of 10 best biotech stocks under $6 in 2021. In December 2020, the firm entered into an agreement with a UAE company for the marketing and selling of NexoBrid in the Middle Eastern market. The regulatory approval for the drug that treats severe burns is expected to be granted within a year. At the end of the fourth quarter of 2020, 2 hedge funds in the database of Insider Monkey held stakes worth $2.5 million in the firm, the same as in the preceding quarter having stakes worth $2.4 million.